(Q43416620)

23 November 2017

title

Dopamine might not be involved in the pathogenesis of polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

23 November 2017

main subject

1 reference

1 reference

Ferriani RA

1

1 reference

23 November 2017

Silva de Sá MF

2

1 reference

23 November 2017

Moura MD

3

1 reference

23 November 2017

Moreira AC

4

1 reference

23 November 2017

Gomes UA

5

1 reference

23 November 2017

language of work or name

1 reference

1 December 1989

1 reference

Gynecological Endocrinology

23 November 2017

published in

1 reference

23 November 2017

volume

3

1 reference

23 November 2017

issue

4

1 reference

23 November 2017

page(s)

317-327

1 reference

Inappropriate Secretion of Follicle-Stimulating Hormone and Luteinizing Hormone in Polycystic Ovarian Disease

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513598909152471

Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513598909152471

The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513598909152471

Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513598909152471

Variability and selectivity of anterior pituitary response to dopamine agonists throughout the normal menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513598909152471

10.3109/09513598909152471

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference